MX2009011444A - Titulacion del tapentadol. - Google Patents

Titulacion del tapentadol.

Info

Publication number
MX2009011444A
MX2009011444A MX2009011444A MX2009011444A MX2009011444A MX 2009011444 A MX2009011444 A MX 2009011444A MX 2009011444 A MX2009011444 A MX 2009011444A MX 2009011444 A MX2009011444 A MX 2009011444A MX 2009011444 A MX2009011444 A MX 2009011444A
Authority
MX
Mexico
Prior art keywords
tapentadol
titration
dose
administration unit
pain
Prior art date
Application number
MX2009011444A
Other languages
English (en)
Inventor
Claudia Lange
Ferdinand Rombout
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38123877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009011444(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of MX2009011444A publication Critical patent/MX2009011444A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Adhesive Tapes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere al uso de tapentadol para la manufactura de un medicamento que comprende, al menos una unidad de administración A que contiene la dosis a de tapentadol y al menos una unidad de administración E que contiene la dosis b de tapentadol, en donde la dosis a < dosis b, para el tratamiento de dolor.
MX2009011444A 2007-04-23 2008-04-21 Titulacion del tapentadol. MX2009011444A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07008218A EP1985292A1 (en) 2007-04-23 2007-04-23 Titration of tapentadol
PCT/EP2008/003178 WO2008128740A1 (en) 2007-04-23 2008-04-21 Titration of tapentadol

Publications (1)

Publication Number Publication Date
MX2009011444A true MX2009011444A (es) 2009-11-05

Family

ID=38123877

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011444A MX2009011444A (es) 2007-04-23 2008-04-21 Titulacion del tapentadol.

Country Status (22)

Country Link
US (4) US20090012180A1 (es)
EP (5) EP1985292A1 (es)
JP (4) JP5933176B2 (es)
KR (3) KR20100017267A (es)
CN (1) CN101730530B (es)
AT (1) ATE534378T1 (es)
AU (1) AU2008241013B2 (es)
CA (1) CA2683786C (es)
CY (1) CY1112320T1 (es)
DK (1) DK2148670T3 (es)
ES (1) ES2378255T3 (es)
HK (1) HK1140940A1 (es)
HR (1) HRP20120147T1 (es)
IL (1) IL201479A (es)
MX (1) MX2009011444A (es)
NZ (1) NZ580415A (es)
PL (1) PL2148670T3 (es)
PT (1) PT2148670E (es)
RU (1) RU2472497C2 (es)
SI (1) SI2148670T1 (es)
WO (1) WO2008128740A1 (es)
ZA (1) ZA200907355B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
PE20142368A1 (es) * 2008-10-30 2015-02-04 Gruenenthal Chemie Formas de dosificacion del tapentadol novedosas y potentes
US8870876B2 (en) * 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) * 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US20130116333A1 (en) * 2010-05-05 2013-05-09 Ratiopharm Gmbh Solid tapentadol in non-crystalline form
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
SI2588093T1 (sl) * 2010-06-30 2016-10-28 Gruenenthal Gmbh Tapentadol za uporabo pri zdravljenju sindroma razdražljivega črevesja
PT3656765T (pt) * 2010-07-23 2021-05-25 Gruenenthal Gmbh Sais ou cocristais de 3-(3-dimetilamino-1-etil-2- metilpropil)fenol
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
RS54711B1 (en) * 2011-03-04 2016-08-31 Grünenthal GmbH PARENTERAL TAPENTADOL ADMINISTRATION
KR102039320B1 (ko) 2011-03-04 2019-11-01 그뤼넨탈 게엠베하 타펜타돌을 함유하는 반고체 수성 약제학적 조성물
PT3287123T (pt) 2011-03-04 2020-05-22 Gruenenthal Gmbh Formulação farmacêutica aquosa de tapentadol para administração oral
US20120309840A1 (en) * 2011-04-05 2012-12-06 Gruenenthal Gmbh Treatment of Pain Associated with Trigeminal Neuralgia
DK2694049T3 (da) 2011-04-05 2019-01-02 Gruenenthal Gmbh Tapentadol til forebyggelse af kronificering af smerte
US20120277319A1 (en) 2011-04-29 2012-11-01 Gruenenthal Gmbh Use of Tapentadol for Inhibiting and/or Treating Depression and Anxiety
WO2014152296A1 (en) * 2013-03-15 2014-09-25 Mallinckrodt Llc Abuse deterrent solid dosage form for immediate release with functional score
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
PL3273953T3 (pl) 2015-03-27 2019-07-31 Grünenthal GmbH Stabilny preparat do pozajelitowego podawania tapentadolu
WO2016190766A1 (en) * 2015-05-26 2016-12-01 Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa Compositions for use in treating parkinson's disease and related disorders
JP7373904B2 (ja) * 2016-02-29 2023-11-06 パーク・セラピューティクス・インコーポレイテッド セブラノパドールの滴定
MX2019003257A (es) 2016-09-23 2019-06-10 Gruenenthal Gmbh Formulacion estable para la administracion parenteral de tapentadol.
WO2021185804A1 (en) 2020-03-16 2021-09-23 Grünenthal GmbH Scored tablet
CN117042738A (zh) * 2021-03-17 2023-11-10 埃科特莱茵药品有限公司 药物剂量系统
EP4333820A1 (en) * 2021-05-07 2024-03-13 Grünenthal GmbH Tapentadol for treating neuropathic pain in covid-19 patients

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
JPS6327805A (ja) 1986-07-21 1988-02-05 Sumitomo Electric Ind Ltd 光フアイバの接続用部材及びそれを用いた接続方法
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
PT1572167E (pt) 2002-12-13 2008-10-03 Euro Celtique Sa Regime posológico de buprenorfina papa analgesia
US7413749B2 (en) 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
DE102007019417A1 (de) 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol

Also Published As

Publication number Publication date
CY1112320T1 (el) 2015-12-09
ES2378255T3 (es) 2012-04-10
RU2472497C2 (ru) 2013-01-20
CA2683786C (en) 2021-10-26
US20090012180A1 (en) 2009-01-08
EP3143993A1 (en) 2017-03-22
WO2008128740A1 (en) 2008-10-30
ZA200907355B (en) 2010-08-25
JP2019131598A (ja) 2019-08-08
DK2148670T3 (da) 2012-03-12
JP2016128468A (ja) 2016-07-14
PL2148670T3 (pl) 2012-04-30
KR20100017267A (ko) 2010-02-16
CN101730530B (zh) 2013-10-23
HK1140940A1 (en) 2010-10-29
SI2148670T1 (sl) 2012-03-30
RU2009142940A (ru) 2011-05-27
JP2010531296A (ja) 2010-09-24
CN101730530A (zh) 2010-06-09
ATE534378T1 (de) 2011-12-15
EP2148670B1 (en) 2011-11-23
EP1985292A1 (en) 2008-10-29
US20170079938A1 (en) 2017-03-23
AU2008241013A1 (en) 2008-10-30
JP5933176B2 (ja) 2016-06-08
HRP20120147T1 (hr) 2012-03-31
WO2008128740A8 (en) 2010-06-17
IL201479A (en) 2016-04-21
KR102078999B1 (ko) 2020-02-19
EP3603630A1 (en) 2020-02-05
US20190290603A1 (en) 2019-09-26
CA2683786A1 (en) 2008-10-30
KR20150027840A (ko) 2015-03-12
EP2422778A1 (en) 2012-02-29
PT2148670E (pt) 2012-01-24
KR20180004839A (ko) 2018-01-12
NZ580415A (en) 2012-04-27
US20160074342A1 (en) 2016-03-17
IL201479A0 (en) 2010-05-31
US11344512B2 (en) 2022-05-31
JP2018030864A (ja) 2018-03-01
EP2148670A1 (en) 2010-02-03
AU2008241013B2 (en) 2013-06-20

Similar Documents

Publication Publication Date Title
MX2009011444A (es) Titulacion del tapentadol.
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
MX2009013989A (es) Terapia en combinacion para depresion.
HK1148202A1 (en) Pharmaceutical solutions, process of preparation and therapeutic uses
MY153408A (en) Novel methods
HK1129594A1 (en) Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain
WO2010014690A3 (en) Medical devices for therapeutic agent delivery
PH12013501790B1 (en) Use of dpp iv inhibitors
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
NZ707377A (en) Combination therapy methods for treating proliferative diseases
UA105210C2 (ru) Противораковая вакцина и ее применение
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
UA109661C2 (uk) Фармацевтична композиція співкристалів трамадолу і коксибів
NZ591873A (en) Co-crystals of tramadol and nsaids
MX2010002735A (es) Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno.
NZ715686A (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
MX2009003532A (es) Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina.
WO2008092219A3 (en) Pharmaceutical composition comprising tramadol and ketoprofen
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
AR048460A1 (es) Tratamiento de la funcion respiratoria alterada con gaboxadol
WO2007135123A3 (en) Mirtazapine for the treatment of neuropathic pain
EA201000738A1 (ru) Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата
UA99093C2 (ru) Применение фенофибрата или его производного для лечения диабетической ретинопатии
MX2008000780A (es) Combinacion terapeutica que comprende un bloqueador de receptores nmda y una sustancia narcotica analgesica.

Legal Events

Date Code Title Description
FG Grant or registration